Heterogeneous Protein Thiol Oxidation after DiMethoxyNaphthoQuinone (DMNQ) Metabolism in A549 Lung Cancer Cells

Poster Number

9B

Lead Author Affiliation

Pharm.D. Student

Lead Author Status

Doctoral Student

Second Author Affiliation

Pharm.D. Student

Second Author Status

Doctoral Student

Third Author Affiliation

Pharm.D. Student

Third Author Status

Doctoral Student

Fourth Author Affiliation

Pharm.D. student

Fourth Author Status

Doctoral Student

Fifth Author Affiliation

Pharm.D. Student

Fifth Author Status

Doctoral Student

Sixth Author Affiliation

Pharm.D. Student

Sixth Author Status

Doctoral Student

Additional Authors

De La Torre Gonzalez, Monica, Biochemistry Undergraduate Student

Tran, Phi-Nhat, Pharm.D. Student, Doctoral Student

Singh, Sonia, Prepharmacy Undergraduate Student

Rahman, Md. Anisur, Ph.D. Physiology/Pharmacology Doctoral Student

Livesey, John C, Physiology/Pharmacology Faculty

Introduction/Abstract

Cancer metastasis is present in, or responsible for, an estimated 90% of cancer deaths from solid tumors. Epithelial Mesenchymal Transition (EMT) is a cellular program that interconverts epithelial cells (lining or covering organs) to mesenchymal cells (migratory and less differentiated cells) and is regulated by multiple signaling pathways. A process called reduction-oxidation (redox) signaling, a series of chemical reactions within the cells, is also thought to trigger EMT. However, the protein target of redox signaling in EMT is unknown.

Purpose

To identify the predominant protein target of peroxide-dependent oxidation in redox signaling leading to epithelial mesenchymal transition in lung cancer.

Method

Cultured human A549 lung cancer cells were treated with 5 or 10 µM 2,3-DiMethoxyNaphthoQuinone (DMNQ) for 1 hour. Cells were lysed in the presence of fluorescein-5-maleimide for labeling of native free thiols. Samples were then further derivatized by chemical reduction of thiol oxidation products, derivatized with a second fluorescent maleimide to label reducible oxidation products, and analyzed using the RedoxiFluor method of Tuncay et al. 2022.

Results

Treatment of cells with DMNQ resulted in a significant global redox decrease in the cellular content of reduced protein thiols (as a percentage of total reducible thiols). However, investigation of specific proteins within EMT regulatory networks has not yielded substantial changes in the ratio of reduced to total thiol content. Specific proteins investigated were SMAD2/3, beta-catenin, Akt, and SNAI1/2.

Significance

A large global redox change in cells was successfully measured after the metabolism of a drug (DMNQ) that generates superoxide anion radical and hydrogen peroxide. While similar oxidation events triggered EMT, specific oxidation-influenced protein targets have not yet been identified. This result implies a heterogeneous reactivity among cellular protein thiols which may provide regulatory control over cellular processes.

Location

Library and Learning Center, 3601 Pacific Ave., Stockton, CA 95211

Format

Poster Presentation

This document is currently not available here.

Share

COinS
 
Apr 29th, 10:00 AM Apr 29th, 12:00 PM

Heterogeneous Protein Thiol Oxidation after DiMethoxyNaphthoQuinone (DMNQ) Metabolism in A549 Lung Cancer Cells

Library and Learning Center, 3601 Pacific Ave., Stockton, CA 95211

Cancer metastasis is present in, or responsible for, an estimated 90% of cancer deaths from solid tumors. Epithelial Mesenchymal Transition (EMT) is a cellular program that interconverts epithelial cells (lining or covering organs) to mesenchymal cells (migratory and less differentiated cells) and is regulated by multiple signaling pathways. A process called reduction-oxidation (redox) signaling, a series of chemical reactions within the cells, is also thought to trigger EMT. However, the protein target of redox signaling in EMT is unknown.